Skip to main content

Table 1 Baseline characteristics (demographic and presentation) of coronary artery bypass patients according to neutrophil lymphocyte ratios (NLR) and surgical approach (MICS vs. Sternotomy CABG)

From: Elevated preoperative neutrophil/lymphocyte ratio as a predictor of increased long-term survival in minimal invasive coronary artery bypass surgery compared to sternotomy

Variables

NLR <2.3 (N = 371)

p Value

2.3 ≤ NLR ≤ 3.4 (N = 375)

p Value

NLR >3.4 (N = 380)

p Value

 

Sternotomy CABG

MICS

 

Sternotomy CABG

MICS

 

Sternotomy CABG

MICS

 

n

242

129

 

245

130

 

243

137

 

Age (years)

62.5 ± 10.2

60.7 ± 10.9

0.12

64.3 ± 11.0

62.6 ± 10.7

0.14

67.5 ± 11.0

65.6 ± 10.7

0.10

Male

174 (71.9%)

90 (69.8%)

0.67

172 (70.5%)

93 (71.0%)

0.92

178 (73.3%)

100 (73.0%)

0.96

Race (Caucasian)

200 (82.6%)

106 (82.2%)

0.09

218 (89.3%)

123 (93.9%)

0.14

227 (93.4%)

128 (93.4%)

1.00

Body Mass Index (kg/m2)

29.1 ± 5.09

29.4 ± 5.42

0.65

30.0 ± 5.70

29.9 ± 6.22

0.95

28.8 ± 5.50

28.7 ± 5.71

0.81

Death

21 (8.7%)

9 (7.0%)

0.57

32 (13.1%)

17 (13.0%)

0.97

57 (23.5%)

18 (13.1%)

0.02

Family history of CAD

101 (41.7%)

63 (48.8%)

0.19

79 (32.4%)

45 (34.4%)

0.7

89 (36.6%)

41 (29.9%)

0.19

Smoking

149 (62.9%)

65 (50.4%)

0.02

141 (59.7%)

72 (55.4%)

0.42

134 (55.6%)

69 (50.4%)

0.33

Hypertension

172 (71.1%)

98 (76.6%)

0.26

180 (74.1%)

93 (71.0%)

0.52

181 (74.5%)

113 (83.1%)

0.05

Diabetes mellitus

94 (38.8%)

33 (25.6%)

0.01

73 (29.9%)

33 (25.2%)

0.33

96 (39.5%)

47 (34.3%)

0.32

Peripheral arterial disease

29 (12.0%)

13 (10.1%)

0.58

36 (14.8%)

7 (5.3%)

0.006

39 (16.0%)

14 (10.2%)

0.12

Renal failure on dialysis

3 (1.2%)

1 (0.8%)

0.68

3 (1.2%)

5 (3.8%)

0.1

8 (3.3%)

9 (6.6%)

0.14

Myocardial infarction

134 (55.4%)

51 (39.5%)

0.004

132 (54.1%)

52 (39.7%)

0.008

130 (53.5%)

38 (27.7%)

<0.001

History of PCI

71 (29.3%)

23 (17.8%)

0.02

66 (27.0%)

31 (23.7%)

0.48

58 (23.9%)

23 (16.8%)

0.11

Prior CABG

7 (2.9%)

2 (1.6%)

0.51

7 (2.9%)

1 (0.8%)

0.27

9 (3.7%)

2 (1.5%)

0.34

Prior heart failure

37 (15.3%)

7 (5.4%)

0.005

41 (16.8%)

9 (6.9%)

0.007

45 (18.5%)

11 (8.0%)

0.01

Prior cerebrovascular event

31 (12.8%)

8 (6.2%)

0.048

39 (16.0%)

11 (8.4%)

0.04

50 (20.6%)

12 (8.8%)

0.003

C0PD

30 (12.4%)

10 (7.9%)

0.18

34 (13.9%)

16 (12.2%)

0.64

34 (14.0%)

16 (11.7%)

0.52

Preoperative CCS

         

none

0 (0%)

1 (0.8%)

0.14

2 (0.8%)

0 (0%)

0.02

2 (0.8%)

0 (0%)

<0.001

Class I

42 (17.6%)

24 (18.6%)

 

34 (13.9%)

32 (24.4%)

 

41 (17.2%)

28 (20.6%)

 

Class II

61 (25.5%)

45 (34.9%)

 

74 (30.3%)

47 (35.9%)

 

46 (19.3%)

49 (36.0%)

 

Class III

68 (28.5%)

33 (25.6%)

 

75 (30.7%)

29 (22.1%)

 

83 (34.9%)

45 (33.1%)

 

Class IV

68 (28.5%)

26 (20.2%)

 

59 (24.2%)

23 (17.6%)

 

66 (27.7%)

14 (10.3%)

 

NYHA

         

Class I

22 (17.9%)

21 (19.4%)

0.21

25 (29.2%)

25 (24.0%)

0.31

30 (23.8%)

22 (21.2%)

0.03

Class II

33 (26.8%)

40 (37.0%)

 

42 (32.3%)

39 (37.5%)

 

26 (20.6%)

33 (31.7%)

 

Class III

44 (35.8%)

26 (24.1%)

 

37 (28.5%)

19 (18.3%)

 

38 (30.2%)

37 (35.6%)

 

Class IV

24 (19.5%)

21 (19.4%)

 

26 (20.0%)

21 (20.2%)

 

32 (25.4%)

12 (11.5%)

 

Ejection Fraction (%)

39.8 ± 12.1

41.0 ± 10.8

0.32

39.1 ± 12.1

41.6 ± 10.4

0.04

39.3 ± 12.8

41.2 ± 12.4

0.17

Preoperative laboratory values

         

Leukocyte (k/cc)

7.42 ± 2.31

7.20 ± 2.03

0.37

8.09 ± 2.22

7.61 ± 2.20

0.05

9.70 ± 3.13

8.87 ± 2.71

0.01

Neutrophils (k/cc)

4.06 ± 1.35

3.94 ± 1.29

0.40

5.28 ± 1.55

4.97 ± 1.51

0.06

7.45 ± 2.82

6.76 ± 2.45

0.01

Lymphocytes (k/cc)

2.45 ± 1.10

2.40 ± 0.763

0.40

1.91 ± 0.566

1.79 ± 0.533

0.06

1.35 ± 0.462

1.29 ± 0.455

0.24

Monocytes (k/cc)

0.62 ± 0.286

0.62 ± 0.241

0.80

0.65 ± 0.263

0.60 ± 0.225

0.12

0.69 ± 0.299

0.62 ± 0.237

0.02

Creatinine (mg/dl)

1.06 ± 0.741

1.07 ± 0.983

0.99

1.14 ± 0.711

1.19 ± 1.02

0.56

1.26 ± 0.61

1.18 ± 0.604

0.06

Glucose (mg/dl)

124.0 ± 48.9

122.4 ± 52.4

0.76

126.1 ± 49.3

110.8 ± 41.6

0.002

136.2 ± 58.8

121.5 ± 46.3

0.01

  1. CABG  coronary artery bypass grafting, CAD  coronary artery disease, CCS  Canadian Cardiovascular Society Angina classification system, COPD  chronic obstructive pulmonary disease, NYHA  New York Heart Association Functional Classification, PCI  percutaneous coronary intervention. Categorical variables were presented as frequencies and percentages; continuous variables were presented as means and standard deviations.